HUTCHMED (LON:HCM) Stock Crosses Above Two Hundred Day Moving Average of $267.72

HUTCHMED (China) Limited (LON:HCM) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 267.72 ($3.31) and traded as high as GBX 303 ($3.74). HUTCHMED shares last traded at GBX 296 ($3.66), with a volume of 53,747 shares changing hands.

HUTCHMED Price Performance

The firm has a market capitalization of £2.62 billion, a P/E ratio of 2,960.00 and a beta of 0.68. The company has a debt-to-equity ratio of 11.59, a current ratio of 2.72 and a quick ratio of 2.97. The company’s 50 day moving average price is GBX 259.83 and its 200 day moving average price is GBX 267.72.

About HUTCHMED

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.